Trump Tariff Threats Put Swiss Pharma Industry on Alert
Swiss pharmaceutical sector faces potential disruption as Trump administration signals new tariff plans, with industry leaders expressing concerns over possible production relocations

Key Takeaways
- Pharmaceuticals account for 60% of all goods exported from Switzerland to the United States.
- Swiss companies employ between 300,000 and 400,000 people within the United States.
- Roche employs approximately 25,000 people in the US.
- UBS forecasts adjusted economic growth of 1.5% for Switzerland in the current year.
- The US trade balance with Switzerland is nearly equalized when services are included, despite a deficit in goods.
By The Numbers
They Said
"We are relatively relaxed because we have the entire value chain on site in the US."
"Such a relocation would have a significant impact on Switzerland in terms of value creation and tax revenues."